Literature DB >> 2253396

Comparison of the effects of purified human alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor on NK cytotoxicity: only alpha 1-proteinase inhibitor inhibits natural killing.

A Laine1, A Leroy, E Hachulla, M Davril, J P Dessaint.   

Abstract

While an inhibitory effect on natural killer (NK) cell activity was demonstrated with partially purified alpha 1 Achy, neither highly purified alpha 1 Achy from two healthy donors nor from one patient with giant-cell arteritis, which carries more highly branched glycans, inhibited the NK cytotoxicity. Our purification procedure, based on immunoaffinity chromatography and gel filtration, was not in question since the pure alpha 1-proteinase inhibitor (alpha 1PI) prepared in our laboratory by using a similar procedure continued to inhibit the NK cytotoxicity. If an inhibitory effect not related to antiprotease activity occurs with alpha 1PI, it is surprising that it is not shared by alpha 1 Achy which, like alpha 1PI, belongs to the serpin family and which possesses a strong structural homology with alpha 1PI. Our finding that alpha 1PI is able to affect human NK cytotoxicity while alpha 1 Achy (even with more highly branched glycans) is unable to suggests that events controlling NK activity may involve other enzymes than chymotrypsin-like enzymes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253396     DOI: 10.1016/0009-8981(90)90170-w

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  S-glutathionylated serine proteinase inhibitors as plasma biomarkers in assessing response to redox-modulating drugs.

Authors:  Christina L Grek; Danyelle M Townsend; Joachim D Uys; Yefim Manevich; Woodrow J Coker; Christopher J Pazoles; Kenneth D Tew
Journal:  Cancer Res       Date:  2012-03-08       Impact factor: 12.701

2.  Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinoma.

Authors:  Mehdi Farshchian; Atte Kivisaari; Risto Ala-Aho; Pilvi Riihilä; Markku Kallajoki; Reidar Grénman; Juha Peltonen; Taina Pihlajaniemi; Ritva Heljasvaara; Veli-Matti Kähäri
Journal:  Am J Pathol       Date:  2011-07-01       Impact factor: 4.307

3.  Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer.

Authors:  R Shakya; G A Tarulli; L Sheng; N A Lokman; C Ricciardelli; K I Pishas; C I Selinger; M R J Kohonen-Corish; W A Cooper; A G Turner; P M Neilsen; D F Callen
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

4.  Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity.

Authors:  H Kataoka; H Uchino; T Iwamura; M Seiki; K Nabeshima; M Koono
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

Review 5.  From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel Biomarkers.

Authors:  Vlad Voiculescu; Bogdan Calenic; Mihaela Ghita; Mihai Lupu; Ana Caruntu; Liliana Moraru; Suzana Voiculescu; Alexandra Ion; Maria Greabu; Nikolay Ishkitiev; Constantin Caruntu
Journal:  Dis Markers       Date:  2016-08-23       Impact factor: 3.434

6.  Clinical Significance of SERPINA1 Gene and Its Encoded Alpha1-antitrypsin Protein in NSCLC.

Authors:  Evrim Ercetin; Sarah Richtmann; Beatriz Martinez Delgado; Gema Gomez-Mariano; Sabine Wrenger; Elena Korenbaum; Bin Liu; David DeLuca; Mark P Kühnel; Danny Jonigk; Kadriya Yuskaeva; Arne Warth; Thomas Muley; Hauke Winter; Michael Meister; Tobias Welte; Sabina Janciauskiene; Marc A Schneider
Journal:  Cancers (Basel)       Date:  2019-09-04       Impact factor: 6.639

Review 7.  Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.

Authors:  Sherri A Smith; Nigel J Waters
Journal:  Pharm Res       Date:  2018-12-28       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.